SYNCROSOME will be présent at Bio International Convention in Chicago on April 22th - 25th, 2013.
As you know SYNCROSOME is a CRO focused on in vivo efficacy studies dedicated to discovery and preclinical stage with more than 25 animals models, to provide you the right data to make the right decision.
We offer our services and our expertise in the development of drugs in :
- Central Nervous System
- Metabolism Disorder
Syncrosome is a preclinical CRO dedicated to In vivo pharmacology since 12 years now and with a strong competency in Efficacy and Pharmacokinetics.
One of our department is dedicated to Central Nervous System and we propose a complete offer with:
- In vivo efficacy models in Parkinson and Stroke
- CNS-PK with Microdialysis and CSF sampling
Sandra Robelet, Head of CNS department, will attend the 8th Annual Biomarkers Congress, 19 & 20 Feb 2013, Manchester. It will ...
Syncrosome is a Preclinical Drug Evaluation Company specialised in human and animal health in vivo pharmacological studies. Syncrosome has the professional expertise to complete studies independently or to work in parallel with in-house research teams, after preliminary in vitro screenings - www.syncrosome.com